Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-31

FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approved Aurolife Pharma, LLC's dextroamphetamine sulfate as an original-application generic, authorizing a generic stimulant for attention-deficit/hyperact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

ORIG AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)